Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis

医学 肺癌 肺炎 不利影响 危险系数 回顾性队列研究 内科学 放射治疗 优势比 癌症 胃肠病学 置信区间
作者
Nikolaj Frost,Kristina Unger,Torsten Blum,Daniel Misch,S Kurz,H Lüders,Elisabeth Olive,Matthias Raspe,Moritz Hilbrandt,Myriam Koch,Dirk Böhmer,Carolin Senger,Martin Witzenrath,Christian Grohé,Torsten Bauer,Dominik Paul Modest,Jens Kollmeier
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:179: 107184-107184 被引量:9
标识
DOI:10.1016/j.lungcan.2023.107184
摘要

Introduction Checkpoint-inhibitor pneumonitis (CIP) represents a major immune-related adverse event (irAE) in patients with lung cancer. We aimed for the clinical characterization, diagnostics, risk factors, treatment and outcome in a large cohort of patients from everyday clinical practice. Patients and methods For this retrospective analysis, 1,376 patients having received checkpoint inhibitors (CPI) in any line of therapy from June 2015 until February 2020 from three large-volume lung cancer centers in Berlin, Germany were included and analyzed. Results With a median follow-up of 35 months, all-grade, high-grade (CTCAE ≥ 3) and fatal CIP were observed in 83 (6.0%), 37 (2.7%) and 12 (0.9%) patients, respectively, with a median onset 4 months after initiation of CPI therapy. The most common radiologic patterns were organizing pneumonia (OP) and non-specific interstitial pneumonia (NSIP) (37% and 31%). All except 7 patients with G1-2 CIP interrupted treatment. Corticosteroids were administered to 74 patients with a median starting dose of 0.75 mg/kg. After complete restitution (n = 67), re-exposure to CPI (n = 14) led to additional irAE in 43% of the cases. Thoracic radiotherapy targeting the lung was the only independent risk factor for CIP (odds ratio 2.8, p < 0.001) and pretherapeutic diffusing capacity for carbon monoxide inversely correlated with CIP severity. Compared with patients without CIP and non-CIP irAE, CIP was associated with impaired overall survival (hazard ratios 1.23, p = 0.24 and 2.01, p = 0.005). Conclusions High-grade CIP accounts for almost half of all CIP cases in an allcomer lung cancer population. A continuous vigilance, rapid diagnostics and adequate treatment are key to prevent disease progression associated with impaired survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科目三应助彭栋采纳,获得10
2秒前
方文浩发布了新的文献求助10
2秒前
ding应助YWang采纳,获得10
5秒前
5秒前
林宝雯关注了科研通微信公众号
10秒前
13秒前
斯文败类应助GGBOND采纳,获得10
13秒前
星辰大海应助科研通管家采纳,获得10
13秒前
李健的小迷弟应助GGBOND采纳,获得10
13秒前
上官若男应助科研通管家采纳,获得10
13秒前
14秒前
大模型应助科研通管家采纳,获得10
14秒前
圆锥香蕉应助科研通管家采纳,获得20
14秒前
星辰大海应助科研通管家采纳,获得10
14秒前
14秒前
14秒前
Bio应助科研通管家采纳,获得30
14秒前
科研通AI5应助科研通管家采纳,获得10
14秒前
斯文败类应助科研通管家采纳,获得10
14秒前
汉堡包应助科研通管家采纳,获得10
14秒前
15秒前
18秒前
20秒前
20秒前
Dotson发布了新的文献求助10
21秒前
sinsinsin发布了新的文献求助10
22秒前
CodeCraft应助娇气的天亦采纳,获得10
23秒前
24秒前
权思远发布了新的文献求助10
24秒前
彭栋发布了新的文献求助10
24秒前
量子星尘发布了新的文献求助10
25秒前
李爱国应助收集快乐采纳,获得10
26秒前
守墓人完成签到 ,获得积分10
27秒前
28秒前
科研通AI5应助xiaoxiao采纳,获得10
31秒前
顾矜应助权思远采纳,获得10
31秒前
苯氮小羊完成签到,获得积分10
31秒前
33秒前
33秒前
36秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989115
求助须知:如何正确求助?哪些是违规求助? 3531367
关于积分的说明 11253688
捐赠科研通 3269986
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882078
科研通“疑难数据库(出版商)”最低求助积分说明 809105